83_FR_20168 83 FR 20080 - Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Rural Health Opioid Program Grant Performance Measures, OMB No. 0906-xxxx-NEW

83 FR 20080 - Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Rural Health Opioid Program Grant Performance Measures, OMB No. 0906-xxxx-NEW

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration

Federal Register Volume 83, Issue 88 (May 7, 2018)

Page Range20080-20081
FR Document2018-09668

In compliance with the Paperwork Reduction Act of 1995, HRSA has submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. HRSA published the 60-day notice on December 15, 2017, FR Doc. 2017-27013. HRSA received one comment. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period.

Federal Register, Volume 83 Issue 88 (Monday, May 7, 2018) 
[Federal Register Volume 83, Number 88 (Monday, May 7, 2018)]
[Notices]
[Pages 20080-20081]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-09668]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Agency Information Collection Activities: Submission to OMB for 
Review and Approval; Public Comment Request; Rural Health Opioid 
Program Grant Performance Measures, OMB No. 0906-xxxx--NEW

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act of 1995, HRSA 
has submitted an Information Collection Request (ICR) to the Office of 
Management and Budget (OMB) for review and approval. HRSA published the 
60-day notice on December 15, 2017, FR Doc. 2017-27013. HRSA received 
one comment. Comments submitted during the first public review of this 
ICR will be provided to OMB. OMB will accept further comments from the 
public during the review and approval period.

DATES: Comments on this ICR should be received no later than June 6, 
2018.

ADDRESSES: Submit your comments, including the ICR Title, to the desk 
officer for HRSA, either by email to OIRA_submission@omb.eop.gov or by 
fax to (202) 395-5806.

FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance 
requests submitted to OMB for review, email Lisa Wright-Solomon, the 
HRSA Information Collection Clearance Officer at paperwork@hrsa.gov or 
call (301) 443-1984.

SUPPLEMENTARY INFORMATION: 
    Information Collection Request Title: Rural Health Opioid Program 
Grant Performance Measures
    OMB No. 0906-xxxx--NEW
    Abstract: The Rural Health Opioid Program aims to promote rural 
health care services outreach by expanding the delivery of opioid 
related health care services to rural communities. The program will 
work to reduce the morbidity and mortality related to opioid overdoses 
in rural communities through the development of broad community 
consortiums to prepare individuals with opioid-use disorder to start 
treatment, implement care coordination practices to organize patient 
care activities, and support individuals in recovery through the 
enhancement of behavioral counselling and peer support activities.
    Need and Proposed Use of the Information: For this program, 
performance measures were drafted to provide data to the program and to 
enable HRSA to provide aggregate program data required by Congress 
under the Government Performance and Results Act of 1993. These 
measures cover the principal topic areas of interest to the Federal 
Office of Rural Health Policy (FORHP), including: (a) Target population 
demographics; (b) referrals to substance abuse treatment; (c) substance 
abuse treatment process and outcomes; (d) education of health care 
providers and community members; and (e) rates of fatal and non-fatal 
opioid-related overdose. All measures will speak to FORHP's progress 
toward meeting the goals set.
    Likely Respondents: The respondents would be recipients of the 
Rural Health Opioid Program grant funding.
    Burden Statement: Burden in this context means the time expended by 
persons to generate, maintain, retain, disclose or provide the 
information requested. This includes the time needed to review 
instructions; to develop, acquire, install and utilize technology and 
systems for the purpose of collecting, validating and verifying 
information, processing and

[[Page 20081]]

maintaining information, and disclosing and providing information; to 
train personnel and to be able to respond to a collection of 
information; to search data sources; to complete and review the 
collection of information; and to transmit or otherwise disclose the 
information. The total annual burden hours estimated for this ICR are 
summarized in the table below.

                                    Total Estimated Annualized Burden--Hours
----------------------------------------------------------------------------------------------------------------
                                                     Number of                    Average burden
            Form name                Number of     responses per       Total       per response    Total burden
                                    respondents     respondent       responses      (in hours)         hours
----------------------------------------------------------------------------------------------------------------
Rural Health Opioid Program                   10               1              10              11             110
 Grant Performance Measures.....
                                 -------------------------------------------------------------------------------
    Total.......................              10  ..............              10  ..............             110
----------------------------------------------------------------------------------------------------------------


Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-09668 Filed 5-4-18; 8:45 am]
 BILLING CODE 4165-15-P

20080 Federal Register / Vol. 83, No. 88 / Monday, May 7, 2018 / Notices The proposed Rural Quality draft provision of value-based care and disclose or provide the information measures reflect a reduced number of utilization of reimbursement strategies requested. This includes the time required measures and improvements to through Centers for Medicare and needed to review instructions; to the number of optional measures Medicaid quality reporting programs, develop, acquire, install and utilize including the following: 24 total the latest competitive cohort also aligns technology and systems for the purpose measures (previously 43), which with this shift. An increased number of of collecting, validating and verifying includes 16 required measures sophisticated applicants leveraging information, processing and applicable to all awardees in addition to increasingly intricate reporting maintaining information, and disclosing improved optional measure choices for methodologies for quality data and providing information; to train 8 total optional measures (previously 4). collection, utilization, and analysis has personnel and to be able to respond to Proposed revisions specifically include resulted in an estimate of burden hours a collection of information; to search the following: (1) Alignment of clinical more in line with the realities of the measures to current National Quality data sources; to complete and review health care landscape. Forum endorsement recommendations Likely Respondents: The respondents the collection of information; and to and (2) broadened orientation of would be award recipients of the Small transmit or otherwise disclose the measures for improved applicability Health Care Provider Quality information. The total annual burden across variety of rural quality Improvement Program. hours estimated for this ICR are improvement project topic areas. Burden Statement: Burden in this summarized in the table below. With the continuing shift in the context means the time expended by healthcare environment towards persons to generate, maintain, retain, TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Average Number of Total Number of Total burden per Form name responses per burden respondents responses response respondent hours (in hours) Small Health Care Provider Quality Improvement Program Performance Improvement Measurement System (PIMS) Measurement ....................................................... 32 1 32 22 704 32 ........................ 32 ........................ 704 Amy P. McNulty, public during the review and approval individuals in recovery through the Acting Director, Division of the Executive period. enhancement of behavioral counselling Secretariat. DATES: Comments on this ICR should be and peer support activities. [FR Doc. 2018–09674 Filed 5–4–18; 8:45 am] received no later than June 6, 2018. Need and Proposed Use of the BILLING CODE 4165–15–P Information: For this program, ADDRESSES: Submit your comments, performance measures were drafted to including the ICR Title, to the desk provide data to the program and to officer for HRSA, either by email to DEPARTMENT OF HEALTH AND enable HRSA to provide aggregate OIRA_submission@omb.eop.gov or by HUMAN SERVICES program data required by Congress fax to (202) 395–5806. under the Government Performance and Health Resources and Services FOR FURTHER INFORMATION CONTACT: To Results Act of 1993. These measures Administration request a copy of the clearance requests cover the principal topic areas of submitted to OMB for review, email Lisa interest to the Federal Office of Rural Agency Information Collection Wright-Solomon, the HRSA Information Health Policy (FORHP), including: (a) Activities: Submission to OMB for Collection Clearance Officer at Target population demographics; (b) Review and Approval; Public Comment paperwork@hrsa.gov or call (301) 443– referrals to substance abuse treatment; Request; Rural Health Opioid Program 1984. (c) substance abuse treatment process Grant Performance Measures, OMB SUPPLEMENTARY INFORMATION: and outcomes; (d) education of health No. 0906–xxxx—NEW Information Collection Request Title: care providers and community AGENCY: Health Resources and Services Rural Health Opioid Program Grant members; and (e) rates of fatal and non- Administration (HRSA), Department of Performance Measures fatal opioid-related overdose. All Health and Human Services. OMB No. 0906–xxxx—NEW measures will speak to FORHP’s ACTION: Notice. Abstract: The Rural Health Opioid progress toward meeting the goals set. Program aims to promote rural health Likely Respondents: The respondents SUMMARY: In compliance with the care services outreach by expanding the would be recipients of the Rural Health Paperwork Reduction Act of 1995, delivery of opioid related health care Opioid Program grant funding. HRSA has submitted an Information services to rural communities. The Burden Statement: Burden in this Collection Request (ICR) to the Office of program will work to reduce the context means the time expended by Management and Budget (OMB) for morbidity and mortality related to persons to generate, maintain, retain, daltland on DSKBBV9HB2PROD with NOTICES review and approval. HRSA published opioid overdoses in rural communities disclose or provide the information the 60-day notice on December 15, 2017, through the development of broad requested. This includes the time FR Doc. 2017–27013. HRSA received community consortiums to prepare needed to review instructions; to one comment. Comments submitted individuals with opioid-use disorder to develop, acquire, install and utilize during the first public review of this ICR start treatment, implement care technology and systems for the purpose will be provided to OMB. OMB will coordination practices to organize of collecting, validating and verifying accept further comments from the patient care activities, and support information, processing and VerDate Sep<11>2014 17:38 May 04, 2018 Jkt 244001 PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 E:\FR\FM\07MYN1.SGM 07MYN1

Federal Register / Vol. 83, No. 88 / Monday, May 7, 2018 / Notices 20081 maintaining information, and disclosing data sources; to complete and review hours estimated for this ICR are and providing information; to train the collection of information; and to summarized in the table below. personnel and to be able to respond to transmit or otherwise disclose the a collection of information; to search information. The total annual burden TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Average Number of Total Number of Total burden per Form name responses per burden respondents responses response respondent hours (in hours) Rural Health Opioid Program Grant Performance Meas- ures ................................................................................... 10 1 10 11 110 Total .............................................................................. 10 ........................ 10 ........................ 110 Amy P. McNulty, Microbiology and Infectious Diseases Transfer and Development, 31 Center Acting Director, Division of the Executive Research, National Institutes of Health, HHS) Drive Room 4A29, MSC2479, Bethesda, Secretariat. Dated: May 2, 2018. MD 20892–2479; Telephone: +1–301– [FR Doc. 2018–09668 Filed 5–4–18; 8:45 am] Natasha M. Copeland, 435–4507; Fax: +1–301–594–3080; BILLING CODE 4165–15–P Program Analyst, Office of Federal Advisory Email: thalhamc@mail.nih.gov. Committee Policy. SUPPLEMENTARY INFORMATION: The [FR Doc. 2018–09659 Filed 5–4–18; 8:45 am] following represents the intellectual DEPARTMENT OF HEALTH AND BILLING CODE 4140–01–P property to be licensed under the HUMAN SERVICES prospective agreement: U.S. Provisional Patent Application National Institutes of Health DEPARTMENT OF HEALTH AND No. 61/488,671, filed May 20, 2011; PCT HUMAN SERVICES Application. No. PCT/US2012/028926, National Institute of Allergy and filed March 13, 2012; U.S. Patent No. Infectious Diseases; Notice of Closed National Institutes of Health 9,068,003, issued June 30, 2015; U.S. Meeting Patent No. 9,896,511, issued February Pursuant to section 10(d) of the Prospective Grant of Exclusive Patent 20, 2018; and U.S. Patent Application Federal Advisory Committee Act, as License: Antibodies Against TL1A, a No. 15/872,592, filed January 16, 2018, amended, notice is hereby given of the TNF-Family Cytokine, for the ‘‘Antibodies Against TL1A, a TNF- following meeting. Treatment and Diagnosis of Crohn’s Family Cytokine, for the Treatment and The meeting will be closed to the Disease, Ulcerative Colitis, Asthma, Diagnosis of Autoimmune Inflammatory public in accordance with the Psoriasis and Biliary Cirrhosis Diseases’’, NIH Reference No. E–073– provisions set forth in sections AGENCY: National Institutes of Health, 2011/0,1,2. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., With respect to persons who have an HHS. as amended. The contract proposals and obligation to assign their right, title and ACTION: Notice. the discussions could disclose interest to the Government of the United confidential trade secrets or commercial SUMMARY: The National Heart, Lung, and States of America, the patent rights in property such as patentable material, Blood Institute (‘‘NHLBI’’), an institute these inventions have been assigned to and personal information concerning of the National Institutes of Health; an the Government of the United States of individuals associated with the contract agency within the Department of Health America. proposals, the disclosure of which and Human Services, is contemplating The prospective exclusive license would constitute a clearly unwarranted the grant of an exclusive patent license territory may be worldwide and the invasion of personal privacy. to commercialize the invention(s) field of use may be limited to the use embodied in the intellectual property of Licensed Patent Rights for the Name of Committee: National Institute of following: ‘‘Development and Allergy and Infectious Diseases Special estate stated in the Summary Information section of this notice to commercialization of antibodies against Emphasis Panel PHS, 2017–1 NIAID Topic 43 (Adjuvant Development). Precision IBD, Inc., located in San TL1A for the treatment and diagnosis of Date: May 30, 2018. Diego, California, and incorporated Crohn’s Disease, Ulcerative Colitis, Time: 10:30 a.m. to 12:30 p.m. under the laws of Delaware. Asthma, Psoriasis and Biliary Cirrhosis’’ Agenda: To review and evaluate contract The subject technology is based on DATES: Only written comments and/or the use of antibodies against TL1A, a proposals. Place: National Institutes of Health, 5601 applications for a license which are TNF-Family cytokine, for the treatment Fishers Lane, Rockville, MD 20892 received by the NHLBI Office of and diagnosis of autoimmune (Telephone Conference Call). Technology Transfer and Development inflammatory diseases. Autoimmune Contact Person: Thomas F. Conway, Ph.D., on or before May 22, 2018 will be inflammatory diseases occur in greater Scientific Review Officer, Scientific Review considered. than five percent of the U.S. population. daltland on DSKBBV9HB2PROD with NOTICES Program, Division of Extramural Activities, Room 3G51, National Institutes of Health, ADDRESSES: Requests for copies of the Treatments generally include NIAID, 5601 Fishers Lane, MSC 9823, patent application, inquiries, and immunosuppressants or anti- Bethesda, MD 20892–9823, 240–507–9685, comments relating to the contemplated inflammatory drugs, which can have thomas.conway@nih.gov. exclusive license should be directed to: serious side effects. Recently, more (Catalogue of Federal Domestic Assistance Cristina Thalhammer-Reyero, Ph.D., specific immunomodulatory therapies Program Nos. 93.855, Allergy, Immunology, MBA, Senior Licensing and Patenting such as TNF-alpha antagonists have and Transplantation Research; 93.856, Manager, NHLBI Office of Technology been developed. In experiments with VerDate Sep<11>2014 17:38 May 04, 2018 Jkt 244001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\07MYN1.SGM 07MYN1


Document Created: 2018-05-05 02:48:03
Document Modified: 2018-05-05 02:48:03
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
DatesComments on this ICR should be received no later than June 6, 2018.
ContactTo request a copy of the clearance requests submitted to OMB for review, email Lisa Wright-Solomon, the HRSA Information Collection Clearance Officer at [email protected] or call (301) 443-1984.
FR Citation83 FR 20080 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR